References
- McDiarmid, M., and Egan, T., 1988. Acute Occupational Exposure to Antineoplastic Agents, J. Occup. Med. 30 (1988), pp. 984–987.
- Ladik, C., Stoehr, G., and Mauer, M., 1980. Precautionary Methods in the Preparation of Antineoplastics, Am. J. Hosp. Pharm. 37 (1980), pp. 1184–1186.
- Sotaniemi, E., Sutinen, S., Arranto, A., et al., 1983. Liver Damage in Nurses Handling Cytotoxic Agents, Acta Med. Scand. 214 (1983), pp. 181–189.
- Hemminiki, K., Kyyronen, P., and Lindblom, M.-L., 1985. Spontaneous Abortions and Malformations in the Offspring of Nurses Exposed to Anaesthetic Gases, Cytostatic Drugs and Other Hazards in Hospitals, Based on Registered Information of Outcome, J. Epidemiol. Community Health 39 (1985), pp. 141–147.
- Strucker, I., Caillard, J.-F., Collin, R., et al., 1990. Risk of Spontaneous Abortion Among Nurses Handling Antineoplastic Drugs, Scand. J. Work Environ. Health 16 (1990), pp. 102–107.
- Rogers, B., 1987. Investigations of Work-related Exposure to Antineoplastic Agents: An Overview of the Literature, Semin. Occup. Med. 2 (1987), pp. 83–89.
- Cooke, J., Williams, J., Morgan, R., et al., Use of Cytogenetic Methods to Determine Mutagenic Changes in the Blood of Pharmacy Personnel and Nurses who Handle Cytotoxic Agents, Am. J. Hosp. Pharm. 48, pp. 1199–1205.
- Harris, P., Connor, T., Stevens, K., and Theiss, J., 1992. Cytogenetic Assessment of Occupational Exposure of Nurses to Antineoplastic Agents, J. Occup. Med. Tox. 1 (1992), pp. 243–254.
- Hirst, M., Tse, S., Mills, D., et al., 1984. Occupational Exposure to Cyclophosphamide, Lancet i (1984), pp. 186–188.
- Cloak, M., Connor, T., Stevens, K., et al., 1985. Occupational Exposure of Nursing Personnel to Antineoplastic Agents, Oncol. Nurs. Forum. 12 (1985), pp. 33–39.
- 1990. ASHP Technical Assistance Bulletin on Handling Cytotoxic and Hazardous Drugs, Am. J. Hosp. Pharm. 47 (1990), pp. 1033–1049.
- U.S. Department of Labor, 1986. Guidelines for Cytotoxic (Antineoplastic) Drugs. Washington, DC: Occupational Safety and Health Administration, Office of Occupational Medicine; 1986, Pub. No. 8-11.
- Connor, T., Laidlaw, J., Theiss, J., et al., 1984. Permeability of Latex and Polyvinyl Chloride Gloves to Carmustine, Am. J. Hosp. Pharm. 41 (1984), pp. 676–679.
- Laidlaw, J., Connor, T., Theiss, J., et al., 1984. Permeability of Latex and Polyvinyl Gloves to 20 Antineoplastic Drugs, Am. J. Hosp. Pharm. 41 (1984), pp. 2618–2623.
- Thomsen, K., and Millelsen, H., 1975. Protective Capacity of Gloves Used or Handling of Nitrogen Mustard, Cont. Derm. 1 (1975), pp. 268–269.
- Slevin, M., Ang, L., Johnston, A., and Turner, P., 1984. The Efficiency of Protective Gloves Used in the Handling of Cytotoxic Drugs, Cancer Chemother. Pharmacol. 12 (1984), pp. 151–153.
- Laidlaw, J., Connor, T., Theiss, J., et al., 1985. Permeability of Four Disposable Protective-clothing Materials to Seven Antineoplastic Drugs, Am. J. Hosp. Pharm. 42 (1985), pp. 2449–2454.
- Maron, D., and Ames, B., 1983. Revised Methods for the Salmonella Mutagenicity Test, Mutat. Res. 113 (1983), pp. 173–215.
- Matney, T., Nguyen, T., Connor, T., et al., 1985. Genotoxic Classification of Antineoplastic Drugs, Teratogenisis Carcinog. Mutagen. 5 (1985), pp. 319–328.